• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by DuPont de Nemours Inc. (Amendment)

    1/26/24 4:23:47 PM ET
    $DD
    Major Chemicals
    Industrials
    Get the next $DD alert in real time by email
    SC 13G/A 1 us26614n1028_012624.txt us26614n1028_012624.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 4) DUPONT DE NEMOURS INC -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 26614N102 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 26614N102 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 27082208 (6) Shared voting power 0 (7) Sole dispositive power 30389248 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 30389248 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 7.1% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- DUPONT DE NEMOURS INC Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 974 CENTRE ROAD BUILDING 730 WILMINGTON DE 19805 Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- BlackRock, Inc. 2(b) Address or principal business office or, if none, residence: ----------------------------------------------------------------------- BlackRock, Inc. 50 Hudson Yards New York, NY 10001 2(c) Citizenship: -------------------------------------------------------------------- See Item 4 of Cover Page 2(d) Title of class of securities: ------------------------------------------------------------------- Common Stock 2(e) CUSIP No.: See Cover Page Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: [ ] Broker or dealer registered under Section 15 of the Act; [ ] Bank as defined in Section 3(a)(6) of the Act; [ ] Insurance company as defined in Section 3(a)(19) of the Act; [ ] Investment company registered under Section 8 of the Investment Company Act of 1940; [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); [X] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; [ ] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J); [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. Amount beneficially owned: 30389248 Percent of class 7.1% Number of shares as to which such person has: Sole power to vote or to direct the vote 27082208 Shared power to vote or to direct the vote 0 Sole power to dispose or to direct the disposition of 30389248 Shared power to dispose or to direct the disposition of 0 Item 5. Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ]. Item 6. Ownership of More than 5 Percent on Behalf of Another Person If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of DUPONT DE NEMOURS INC. No one person's interest in the common stock of DUPONT DE NEMOURS INC is more than five percent of the total outstanding common shares. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. See Exhibit A Item 8. Identification and Classification of Members of the Group If a group has filed this schedule pursuant to Rule 13d-1(b)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identity of each member of the group. Item 9. Notice of Dissolution of Group Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. Item 10. Certifications By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 26, 2024 BlackRock, Inc. Signature: Spencer Fleming ------------------------------------------- Name/Title Attorney-In-Fact The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001). Exhibit A Subsidiary BlackRock Life Limited BlackRock Advisors, LLC Aperio Group, LLC BlackRock (Netherlands) B.V. BlackRock Institutional Trust Company, National Association BlackRock Asset Management Ireland Limited BlackRock Financial Management, Inc. BlackRock Japan Co., Ltd. BlackRock Asset Management Schweiz AG BlackRock Investment Management, LLC BlackRock Investment Management (UK) Limited BlackRock Asset Management Canada Limited BlackRock (Luxembourg) S.A. BlackRock Investment Management (Australia) Limited BlackRock Advisors (UK) Limited BlackRock Fund Advisors BlackRock Asset Management North Asia Limited BlackRock (Singapore) Limited BlackRock Fund Managers Ltd *Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Exhibit B POWER OF ATTORNEY The undersigned, BlackRock, Inc., a corporation duly organized under the laws of the State of Delaware, United States (the "Company"), does hereby make, constitute and appoint each of Eric Andruczyk, Richard Cundiff, R. Andrew Dickson, III, Spencer Fleming, Daniel Goldmintz, Laura Hildner, Elizabeth Kogut, David Maryles, Christopher Meade, Una Neary, Charles Park, Daniel Riemer, David Rothenberg and Brenda Schulz, acting severally, as its true and lawful attorneys-in-fact, for the purpose of, from time to time, executing, in its name and on its behalf and on behalf of its direct and indirect subsidiaries, any and all documents, certificates, instruments, statements, filings, agreements and amendments (collectively, "documents") determined by such person to be necessary or appropriate to comply with ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, including, without limitation, Schedules 13D and 13G and Forms 3, 4, 5, 13F and 13H and any amendments to any of the foregoing as may be required to be filed with the Securities and Exchange Commission, and delivering, furnishing or filing any such documents with the appropriate governmental or regulatory authority or other person, and giving and granting to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully and to all intents and purposes as the Company and/or its direct and indirect subsidiaries, as applicable, might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said attorney-in-fact shall lawfully do or cause to be done by virtue hereof. Any such determination by an attorney-in-fact named herein shall be conclusively evidenced by such person's execution, delivery, furnishing or filing of the applicable document. This power of attorney shall expressly revoke the power of attorney dated 2nd day of January, 2019 in respect of the subject matter hereof, shall be valid from the date hereof and shall remain in full force and effect until either revoked in writing by the Company, or, in respect of any attorney-in-fact named herein, until such person ceases to be an employee of the Company or one of its affiliates. IN WITNESS WHEREOF, the undersigned has caused this power of attorney to be executed as of this 30th day of April, 2023. BlackRock, Inc. By: /s/ R. Andrew Dickson, III Name: R. Andrew Dickson, III Title: Corporate Secretary
    Get the next $DD alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DD

    DatePrice TargetRatingAnalyst
    7/3/2025$75.00 → $85.00Buy
    Citigroup
    4/15/2025$75.00Underperform → Neutral
    BofA Securities
    4/14/2025$81.00Sector Weight → Overweight
    KeyBanc Capital Markets
    2/13/2025$85.00 → $89.00Underweight → Equal Weight
    Barclays
    1/17/2025$91.00Peer Perform → Outperform
    Wolfe Research
    10/7/2024$88.00 → $84.00Equal Weight → Underweight
    Barclays
    5/28/2024$85.00 → $95.00Neutral → Buy
    Citigroup
    5/24/2024$80.00 → $103.00Equal Weight → Overweight
    Wells Fargo
    More analyst ratings

    $DD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup reiterated coverage on DuPont with a new price target

    Citigroup reiterated coverage of DuPont with a rating of Buy and set a new price target of $85.00 from $75.00 previously

    7/3/25 9:18:04 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont upgraded by BofA Securities with a new price target

    BofA Securities upgraded DuPont from Underperform to Neutral and set a new price target of $75.00

    4/15/25 8:43:17 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont upgraded by KeyBanc Capital Markets with a new price target

    KeyBanc Capital Markets upgraded DuPont from Sector Weight to Overweight and set a new price target of $81.00

    4/14/25 8:04:47 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chair Breen Edward D received a gift of 13,754 shares and gifted 28,111 shares, decreasing direct ownership by 9% to 137,295 units (SEC Form 4)

    4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

    8/22/25 5:09:36 PM ET
    $DD
    Major Chemicals
    Industrials

    Director Lowery Frederick M. was granted 580 shares, increasing direct ownership by 2% to 32,579 units (SEC Form 4)

    4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

    6/3/25 5:10:02 PM ET
    $DD
    Major Chemicals
    Industrials

    Director Cutler Alexander M was granted 749 shares, increasing direct ownership by 1% to 72,865 units (SEC Form 4)

    4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

    6/3/25 5:09:34 PM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $DD
    SEC Filings

    View All

    DuPont Wins Three 2025 R&D 100 Awards

    WILMINGTON, Del., Aug. 21, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that it has won three 2025 R&D 100 Awards in the Mechanical/Materials category. The R&D 100 Awards, sponsored by R&D World Magazine, recognizes the 100 most innovative technologies of the previous year. "We're honored that three of our innovative technologies have been recognized for their game-changing impacts and delivering exceptional performance and value for our customers," said Alexa Dembek, DuPont Chief Technology and Sustainability Officer. "I'm so proud of the dedication and commitment ou

    8/21/25 9:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Water Solutions Wins BIG Sustainability Award for Advancements in Industrial Wastewater Reuse

    Recognized for the commercialization of reverse osmosis and nanofiltration elements that help enable more efficient wastewater treatment and reuse WILMINGTON, Del., Aug. 14, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced that its Water Solutions team has been recognized as a 2025 "Sustainability Squad" in the BIG Sustainability Awards for its work to advance industrial wastewater treatment, reuse and minimal liquid discharge (MLD).   The "Sustainability Squad" Award, presented by the Business Intelligence Group, celebrates the DuPont Water Solutions team's development a

    8/14/25 9:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DUPONT DE NEMOURS, INC. AND QNITY ELECTRONICS, INC. ANNOUNCE PRICING OF SENIOR SECURED NOTES AND SENIOR NOTES

    Notes to be the obligation solely of Qnity Electronics, Inc. as issuer following consummation of DuPont's intended Spin-Off of its electronics business WILMINGTON, Del., Aug. 12, 2025 /PRNewswire/ -- DuPont de Nemours, Inc. (NYSE:DD) ("DuPont") and Qnity Electronics, Inc. ("Qnity") announced today that Qnity priced an offering of $1.0 billion aggregate principal amount of 5.750% senior secured notes due 2032 (the "Secured Notes") and $750.0 million aggregate principal amount of 6.250% senior notes due 2033 (the "Unsecured Notes" and, together with the Secured Notes, the "Notes" and each, a "series of Notes") at a price of 100.000% of the principal amount of the Secured Notes and 100.000% of

    8/12/25 11:35:00 AM ET
    $DD
    Major Chemicals
    Industrials

    SEC Form 8-K filed by DuPont de Nemours Inc.

    8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

    8/15/25 4:25:21 PM ET
    $DD
    Major Chemicals
    Industrials

    DuPont de Nemours Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

    8/12/25 2:33:19 PM ET
    $DD
    Major Chemicals
    Industrials

    DuPont de Nemours Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

    8/11/25 7:30:12 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Financials

    Live finance-specific insights

    View All

    DuPont Reports Second Quarter 2025 Results

    Net Sales of $3.3 billion increased 3%; organic sales increased 2% versus year-ago periodGAAP Income from continuing operations of $238 million; operating EBITDA of $859 millionGAAP EPS from continuing operations of $0.54; adjusted EPS of $1.12Cash provided by operating activities from continuing operations of $381 million; transaction- adjusted free cash flow of $433 millionFull year 2025 guidance raised on stronger second quarter performanceWILMINGTON, Del., Aug. 5, 2025 /PRNewswire/ -- DuPont (NYSE:DD) announced its financial results(1) for the second quarter ended June 30, 2025.

    8/5/25 6:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Schedules Second Quarter 2025 Earnings Conference Call

    WILMINGTON, Del., July 22, 2025 /PRNewswire/ -- DuPont (NYSE:DD) will release its second quarter financial results at 6:00 a.m. ET on Tuesday, August 5, 2025. In addition, the company will host a conference call at 8:00 a.m. ET that day. The event will be webcast live and can be accessed on DuPont's Investors Relations webpage. A replay, along with the earnings release and supporting materials, will also be posted to the website.        The dial-in number for the conference call is 888-440-4172 toll-free within the U.S. or +1-646-960-0673. The conference ID is 5994046. About D

    7/22/25 4:15:00 PM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Publishes 2025 Sustainability Report

    Report highlights strong progress on 2030 Sustainability Goals focused on value creation and risk reduction, with significant achievements on climate action WILMINGTON, Del., July 22, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today published its 2025 Sustainability Report detailing the progress made toward achieving its 2030 Sustainability Goals. "At DuPont, innovation and sustainability are deeply interconnected—and that's reflected in the strong results we've delivered," said Lori Koch, DuPont Chief Executive Officer. "This past year, our teams advanced breakthrough technologies

    7/22/25 8:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by DuPont de Nemours Inc.

    SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)

    11/12/24 11:54:03 AM ET
    $DD
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by DuPont de Nemours Inc. (Amendment)

    SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)

    2/13/24 4:55:53 PM ET
    $DD
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by DuPont de Nemours Inc.

    SC 13G - DuPont de Nemours, Inc. (0001666700) (Subject)

    2/9/24 11:49:03 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Leadership Updates

    Live Leadership Updates

    View All

    DuPont Announces Appointment of Kurt McMaken to Board of Directors

    WILMINGTON, Del., Feb. 21, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced the appointment of Kurt McMaken to its Board of Directors, effective immediately. Mr. McMaken will serve on the Audit committee and Nomination and Governance committee. "We are pleased to welcome Kurt to DuPont's Board of Directors," said DuPont Executive Chairman Ed Breen. "Kurt's global business expertise in the manufacturing sector and extensive background in finance and strategic planning make him well suited to help guide DuPont's growth and value creation strategies. We look forward to his c

    2/21/25 4:15:00 PM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Announces Two Technology Leaders as DuPont Laureates

    Dr. Deyan Wang and Nicholas Sands Recognized for a Career of Innovation and Business Impact; Achieve Highest Technical Level in the Company WILMINGTON, Del., Oct. 10, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced that two of its technology leaders have achieved the professional distinction of DuPont Laureate, the company's most distinguished technical designation. The newly appointed Laureates are Dr. Deyan Wang, DuPont Electronics & Industrial and Nicholas (Nick) Sands of DuPont Water & Protection. "I'm tremendously honored to recognize Deyan and Nick, two of DuPont's

    10/10/24 9:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont to Acquire Donatelle Plastics Incorporated

    Transaction deepens healthcare offerings in medical device solutions WILMINGTON, Del., June 25, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced it has signed an agreement to acquire Donatelle Plastics Incorporated, a leading medical device contract manufacturer specializing in the design, development and manufacture of medical components and devices. The transaction is expected to close in the third quarter 2024, subject to satisfaction of customary closing conditions and receipt of regulatory approvals. "Our healthcare strategy is focused on offering a comprehensive sui

    6/25/24 9:00:00 AM ET
    $DD
    Major Chemicals
    Industrials